|Bid||1.4900 x 0|
|Ask||1.5000 x 0|
|Day's Range||1.4700 - 1.5000|
|52 Week Range||0.8600 - 1.6500|
|Beta (3Y Monthly)||0.07|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 27, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The big shareholder groups in kneat.com, inc. (CVE:KSI) have power over the company. Insiders often own a large chunk...
LIMERICK, Ireland , Sept. 20, 2019 /CNW/ - kneat.com, inc. (KSI.V) ("Kneat" or the "Company") today announced that it has appointed Mr. Hugh Kavanagh as its Chief Financial Officer effective September 23, 2019 following the resignation of Ms. Sarah Oliver who will assist in the transition. Mr. Kavanagh has held senior positions at several multi-national companies in the software and life sciences industries, most recently as Chief Financial Officer of Mainstay Medical during which time he completed an initial public offering and several rounds of funding. "The Board and I are pleased to welcome Hugh to Kneat's executive management team. Kneat will benefit from Hugh's broad financial, operational and capital markets experience as we continue to grow our operations globally", said Eddie Ryan , Chief Executive Officer of Kneat.
LIMERICK, Ireland , Sept. 17, 2019 /CNW/ - kneat.com, inc. (KSI.V) ("Kneat") is pleased to announce that it signed a three-year contract with one of the worlds largest pharmaceutical companies to enable digital transformation for its many validation work processes. This master service agreement allows the customer and its affiliates to expand Kneat Gx across its 100+ global manufacturing sites and represents a significant opportunity for growth and expansion of Kneat's software. Kneat continues to expand its customer pipeline and will report on further developments as they occur.
LIMERICK, Ireland , Aug. 27, 2019 /CNW/ - kneat.com, inc. (KSI.V) ("Kneat") today announced its financial results for the quarter ended June 30 , 2019. All dollar amounts are presented in Canadian dollars unless otherwise stated. During the quarter, two customers deployed our SaaS platform. Year to date, four customers have successfully gone live on our SaaS platform and two customers have started to scale their use of our on-premise solution.
If you own shares in kneat.com, inc. (CVE:KSI) then it's worth thinking about how it contributes to the volatility of...
LIMERICK, Ireland , July 22, 2019 /CNW/ - kneat.com, inc. (KSI.V) ("Kneat") is pleased to announce that a global contract development and manufacturing organization ("CDMO") has selected Kneat's platform to digitize their commissioning, qualification and validation work processes. This customer contracted with Kneat for on-premise perpetual licenses on July 12, 2019 and is expected to go live at a European site on multiple processes by the end of the year. Expansion to all global sites is expected in the future. "We're happy to be fulfilling such a key role within this customer's highly regulated GMP manufacturing facility," said Eddie Ryan , Chief Executive Officer of Kneat.
LIMERICK, Ireland , June 17, 2019 /CNW/ - kneat.com, inc. (KSI.V) ("Kneat") is pleased to announce that a leading company in the field of messenger RNA ("mRNA") has selected Kneat's software as a service ("SaaS") platform for its validation lifecycle management work processes. Initially this customer will configure its computer system validation ("CSV") work process on the platform and expand to other validation processes in the future. Kneat's team will begin deployment at the customer's United States headquarters in the coming weeks with an expected go-live date for CSV in the fourth quarter of 2019. In line with Kneat's typical contracts, this subscription agreement is for three years starting on June 11, 2019 .
HALIFAX , May 28, 2019 /CNW/ - kneat.com, inc. (KSI.V) ("Kneat") today announced its financial results for the quarter ended March 31 , 2019. All dollar amounts are presented in Canadian dollars unless otherwise stated. Kneat announced a new biotechnology customer win during the quarter to add to the seven multinational customers announced in 2018. This customer has over 20,000 employees globally across four continents and will use the Kneat Gx platform ("Kneat Gx") to take their facilities, utilities and equipment commissioning and qualification processes fully digital.
HALIFAX , May 1, 2019 /CNW/ - kneat.com, inc. (KSI.V) ("Kneat") is pleased to announce that Mr. Rory Cameron has been appointed to its Board of Directors. Mr. Cameron has over 15 years of experience in the software industry and an extensive background in mergers, acquisitions and go-to-market operations within global cloud companies. Mr. Cameron recently joined Medallia as Executive Vice President, Corporate Development where he is focusing on accelerating Medallia's growth through new technology partnerships and acquisitions. Prior to joining Medallia, Mr. Cameron was Executive Vice President of Corporate Development at CallidusCloud until its sale to SAP.
HALIFAX , April 24, 2019 /CNW/ - kneat.com, inc. (KSI.V) ("Kneat") today announced its financial results for the quarter and year ended December 31 , 2018. All dollar amounts are presented in Canadian dollars unless otherwise stated. Revenue of $465,205 was recognized during the fourth quarter. Total revenue for the 2018 financial year was $1,307,295 which was an increase of 210% over the previous year. Revenue in all categories increased quarter over quarter and year over year. During the fourth quarter Kneat announced two new software as a service ("SaaS") customer wins within the life sciences supply chain. Both customers have chosen Kneat to implement paperless computer systems validation ("CSV") processes. This is an important market for Kneat as data integrity and compliance regulations govern the entire supply chain to the life sciences industry.
HALIFAX , March 11, 2019 /CNW/ - kneat.com, inc. (KSI.V) ("Kneat") is pleased to announce that an international leader in biotechnology has chosen Kneat's software platform to facilitate its transition to paperless validation processes. With over 20,000 employees globally and manufacturing facilities in four continents, this company develops innovative therapies for patients around the world. Kneat's platform will initially be launched for facilities, utilities and equipment commissioning and qualification ("C&Q") at a manufacturing plant in the United States . "We look forward to working closely with this customer to convert their current paper C&Q process to an end-to-end digital process," said Eddie Ryan , Chief Executive Officer of Kneat. Kneat continues to expand its customer pipeline and will report on further developments as they occur.
This partnership represents a key element in Kneat's strategy to deliver greater value to its current customers and to grow and scale to new customers. Kneat and HCL will work together on projects to provide and implement next generation digital solutions for facilities, equipment and computer systems validation processes using Kneat's paperless software platform and HCL's experience delivering innovative digital solutions to the life sciences industry.
In the news release, Kneat Announces Closing of $6,339,375 Public Equity Financing and Concurrent $2,178,159 Non-Brokered Private Placement Equity Financing, issued 20-Feb-2019 by kneat.com, inc. over CNW, we are advised by the company that a new paragraph was added to the release, the third one below. HALIFAX , Feb. 20, 2019 /CNW/ - kneat.com, inc. (KSI.V) ("Kneat" or the "Company") is pleased to announce that it has closed its previously announced short form prospectus offering, including the full exercise of the over-allotment option. As such, a total of 6,037,500 common shares of the Company were sold at a price of $1.05 per common share (the "Issue Price") for aggregate gross proceeds of $6,339,375 (the "Offering").
"In 2018 we signed seven multinational customers in the life sciences industry and three went live in the second half of 2018 with initial deployments. All three are now expanding their use of the platform. The other four customers are now in the process of their initial deployment and we look forward to working with them as they go-live," said Eddie Ryan , Chief Executive Officer of Kneat. Kneat continues to expand its customer pipeline and will report on further developments as they occur. Kneat develops and markets the next generation Kneat Gx software platform. Multiple business processes can be configured on the platform from equipment to computer system validation, through to quality document management. Kneat's software allows users to author, review, approve, execute testing online, manage any exceptions and post approve final deliverables in a controlled FDA 21 CFR Part 11/ Eudralex Annex 11 compliant platform. Macro and micro report dashboards enable powerful oversight into all systems, projects and processes world wide. Customer case studies are reporting productivity improvements in excess of 100% and a higher data integrity and compliance standard. For more information visit www.kneat.com.
HALIFAX , Feb. 13, 2019 /CNW/ - kneat.com, inc. (KSI.V) ("Kneat") is pleased to announce that a leading laboratory services customer is expanding its user base on the Kneat platform within its flagship site in the United States. This expansion will double the customer's license numbers. This customer first implemented the Kneat platform in December 2018 with the ultimate goal of creating a standardized, compliant and automated equipment and instrument validation process globally. The new licenses will be rolled out immediately. "We are pleased to see our customer increase the number of users within its flagship site", said Eddie Ryan , Chief Executive Officer of Kneat. Kneat continues to expand its customer pipeline and will report on further developments as they occur.
HALIFAX , Feb 7, 2019 /CNW/ - kneat.com, inc. (KSI.V) ("Kneat") is pleased to announce that, in connection with its previously announced overnight marketed offering, it has entered into an underwriting agreement with a syndicate of underwriters led by Cormark Securities Inc., and including Echelon Wealth Partners Inc. and Mackie Research Capital Corporation (collectively, the "Underwriters"), to sell 5,250,000 Common Shares of the Company ("Securities") at a price of $1.05 per Security for aggregate gross proceeds of $5,512 ,500 the "Offering"). Kneat will shortly file an amended and restated preliminary short form prospectus with the securities commissions in all of the provinces of Canada , other than Québec, to reflect the terms of the Offering. Kneat has granted the Underwriters an option (the "Over-Allotment Option") to purchase up to an additional 787,500 of Securities on the same terms as the Offering, exercisable at any time up to 30 days following the closing of the Offering, for market stabilization purposes and to cover over-allotments, if any.
kneat.com, inc. (CVE:KSI) is a small-cap stock with a market capitalization of CA$63m. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end Read More...
HALIFAX , Dec. 20, 2018 /CNW/ - kneat.com, inc. (KSI.V) ("Kneat") is pleased to announce that it has signed a master service agreement with a new customer in the life sciences supply chain. This multi-national customer provides sample lifecycle and logistics management, infrastructure and consumables, including cold storage of biological assets, to global pharmaceutical companies and will now use Kneat's software to automate and simplify their validation processes in the delivery of these services. "Kneat's momentum within the life sciences market continues as industry leaders in the supply chain select our software to drive efficiencies, support data integrity and maintain compliant processes," said Eddie Ryan , Chief Executive Officer of Kneat.